Erythrasma: A report of nine men successfully managed with mupirocin 2% ointment monotherapy

Abstract

Background: Erythrasma is a benign dermatosis that typically occurs on intertriginous skin.

Purpose: We describe a series of nine men with erythrasma that were successfully treated with mupirocin 2% ointment monotherapy.

Methods and materials: We reviewed PubMed for the following terms: erythrasma, mupirocin, ointment, treatment. We also reviewed papers containing these terms and their references.

Results: Complete resolution of erythrasma occurred following monotherapy with twice daily application of mupirocin 2% ointment.

Conclusions: Several topical and oral treatments are available to successfully manage erythrasma. Our series of patients with erythrasma experienced resolution with mupirocin 2% ointment treatment within 2 to 4 weeks of therapy. Monotherapy with mupirocin 2% ointment should be considered as a primary treatment alternative for erythrasma.